StockData
Insulet Corp logo

Insulet Corp (PODD) stock

PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3048% below fair value
$139.98−5.36 (-3.69%)

Close on Nov 18, 2026Market cap $9.71BP/E 22.8Yield –

Insulet gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Insulet's gross profit for the twelve months ending Sep 30, 2026 was $2.29B, up 27.2% year over year. For fiscal 2025 it was $1.94B, up 34.2% from the year before. Over ten years it grew 30.7% a year on average. The highest annual figure on record is $1.94B in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.94B+34.2%
FY2024Dec 31, 2024$1.45B+24.6%
FY2023Dec 31, 2023$1.16B+44.0%
FY2022Dec 31, 2022$805.60M+7.1%
FY2021Dec 31, 2021$752.10M+29.2%
FY2020Dec 31, 2020$582.30M+21.2%
FY2019Dec 31, 2019$480.30M+29.7%
FY2018Dec 31, 2018$370.20M+33.5%
FY2017Dec 31, 2017$277.20M+31.3%
FY2016Dec 31, 2016$211.09M+58.4%
FY2015Dec 31, 2015$133.27M+4.8%
FY2014Dec 31, 2014$127.13M+13.1%
FY2013Dec 31, 2013$112.40M+21.7%
FY2012Dec 31, 2012$92.34M+38.4%
FY2011Dec 31, 2011$66.71M+52.6%
FY2010Dec 31, 2010$43.73M+139.0%
FY2009Dec 31, 2009$18.30M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$632.10M+23.9%
Q2 FY2026Jun 30, 2026$562.60M+24.4%
Q1 FY2026Mar 31, 2026$529.10M+29.4%
Q4 FY2025Dec 31, 2025$568.60M+32.0%
Q3 FY2025Sep 30, 2025$510.10M+35.3%
Q2 FY2025Jun 30, 2025$452.20M+36.7%
Q1 FY2025Mar 31, 2025$409.00M+33.3%
Q4 FY2024Dec 31, 2024$430.90M+19.3%
Q3 FY2024Sep 30, 2024$377.10M+28.6%
Q2 FY2024Jun 30, 2024$330.90M+24.9%
Q1 FY2024Mar 31, 2024$306.80M+27.6%
Q4 FY2023Dec 31, 2023$361.20M+66.2%
Q3 FY2023Sep 30, 2023$293.30M+55.8%
Q2 FY2023Jun 30, 2023$264.90M+39.2%
Q1 FY2023Mar 31, 2023$240.50M+14.7%
Q4 FY2022Dec 31, 2022$217.30M+1.9%
Q3 FY2022Sep 30, 2022$188.30M-0.2%
Q2 FY2022Jun 30, 2022$190.30M+4.2%
Q1 FY2022Mar 31, 2022$209.70M+25.2%
Q4 FY2021Dec 31, 2021$213.20M+32.3%
Q3 FY2021Sep 30, 2021$188.70M+24.3%
Q2 FY2021Jun 30, 2021$182.70M+28.2%
Q1 FY2021Mar 31, 2021$167.50M+32.0%
Q4 FY2020Dec 31, 2020$161.10M+20.1%
Q3 FY2020Sep 30, 2020$151.80M+23.3%
Q2 FY2020Jun 30, 2020$142.50M+22.4%
Q1 FY2020Mar 31, 2020$126.90M+18.9%
Q4 FY2019Dec 31, 2019$134.10M+21.6%
Q3 FY2019Sep 30, 2019$123.10M+20.7%
Q2 FY2019Jun 30, 2019$116.40M+41.8%
Q1 FY2019Mar 31, 2019$106.70M+40.8%
Q4 FY2018Dec 31, 2018$110.30M+38.7%
Q3 FY2018Sep 30, 2018$102.00M+38.5%
Q2 FY2018Jun 30, 2018$82.10M+27.0%
Q1 FY2018Mar 31, 2018$75.80M+27.6%
Q4 FY2017Dec 31, 2017$79.51M+30.5%
Q3 FY2017Sep 30, 2017$73.62M–
Q2 FY2017Jun 30, 2017$64.64M–
Q1 FY2017Mar 31, 2017$59.40M–
Q4 FY2016Dec 31, 2016$60.94M–

More Insulet figures

See a number that looks wrong?